Population-Based Cancer Screening

Victoria L. Champion

Susan M. Rawl

Usha Menon

ONF 2002, 29(5), 853-861. DOI: 10.1188/02.ONF.853-861

Purpose/Objectives: To provide an overview of current issues surrounding the prevention of and screening for lung, breast, cervical, colorectal, ovarian, prostate, and skin cancer.

Data Sources: Original research, review articles, and published guidelines.

Data Synthesis: Although morbidity and mortality rates have decreased for these cancers, prevention and early detection still require increased funding and research.

Conclusions: More behavioral scientists must be trained in prevention and early detection of cancer, and increased research funding is necessary to encourage advances in primary and secondary prevention.

Implications for Nursing: Oncology nurses should incorporate appropriate prevention and early-detection strategies into practice.

Jump to a section

    References

    Adami, H.O., Ponten, J., Sparen, P., Bergstrom, R., Gustafsson, L., & Friberg, L.G. (1994). Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960-1984. Cancer, 73, 140-147.

    Atkin, W.S., Cuzick, J., Northover, J.M., & Whynes, D.K. (1993). Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet, 341, 736-740.

    Austin, J.H., Romney, B.M., & Goldsmith, L.S. (1992). Missed bronchogenic carcinoma: Radiographic findings in 27 patients with a potentially resectable lesion evident in retrospect. Radiology, 182, 115-122.

    Black, W.C. (1999). Lung cancer. New York: Marcel Dekker.

    Blackman, D., Bennett, E., & Miller, D. (1999). Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)-Behavioral Risk Factor Surveillance System. Morbidity and Mortality Weekly Report, 48(SS-6), 1-11.

    Bonfill, X., Marzo, M., Pladevall, M., Arti, J., & Emparanza, J. (2001). Strategies for increasing women's participation in community breast cancer screening [Update software]. Oxford: Cochrane Library.

    Catalona, W.J., Richie, J.P., Ahmann, F.R., Hudson, M.A., Scardino, P.T., Flanigan, R.C., et al. (1994). Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. Journal of Urology, 151, 1283-1290.

    Catalona, W.J., Smith, D.S., Ratliff, T.L., & Basler, J.W. (1993). Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA, 270, 948-954.

    Catalona, W.J., Smith, D.S., Ratliff, T.L., Dodds, K.M., Coplen, D.E., Yuan, J.J., et al. (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine, 324, 1156-1161.

    Champion, V., & Huster, G. (1995). Effect of interventions on stage of mammography adoption. Journal of Behavioral Medicine, 18, 169-187.

    Chavez, L.R., Hubbell, F.A., Mishra, S.I., & Valdez, R.B. (1997). The influence of fatalism on self-reported use of Papanicolaou smears. American Journal of Preventive Medicine, 13, 418-424.

    Colditz, G.A., Rosner, B.A., & Speizer, F.E. (1996). Risk factors for breast cancer according to family history of breast cancer. Journal of the National Cancer Institute, 88, 365-371.

    Eddy, D.M. (1990). Screening for cervical cancer. Annals of Internal Medicine, 113, 214-226.

    Friedman, G.D., Collen, M.F., & Fireman, B.H. (1986). Multiphasic health checkup evaluation: A 16-year follow-up. Journal of Chronic Diseases, 39, 453-463.

    Greenlee, R.T., Hill-Harmon, M.B., Murray, T., & Thun, M. (2001). Cancer statistics, 2001. CA: A Cancer Journal for Clinicians, 51, 15-36.

    Hankinson, S.E., Hunter, D.J., Colditz, G.A., Willett, W.C., Stampfer, M.J., Rosner, B., et al. (1993). Tubal ligation, hysterectomy, and risk of ovarian cancer: A prospective study. JAMA, 270, 2813-2818.

    Hendrick, R.E., Smith, R.A., Rutledge, J.H., III, & Smart, C.R. (1997). Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials. Journal of the National Cancer Institute Monographs, 22, 87-92.

    Henschke, C.I., McCauley, D.I., Yankelevitz, D.F., Naidich, D.P., McGuinness, G., Miettinen, O.S., et al. (1999). Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet, 354, 99-105.

    Imperiale, T.F., Wagner, D.R., Lin, C.Y., Larkin, G.N., Rogge, J.D., & Ransohoff, D.F. (2000). Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. New England Journal of Medicine, 343, 169-174.

    Janz, N.K., Schottenfeld, D., Doerr, K.M., Selig, S.M., Dunn, R.L., Strawderman, M., et al. (1997). A two-step intervention of increase mammography among women aged 65 and older. American Journal of Public Health, 87, 1683-1686.

    Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002). Cancer statistics, 2002. CA-A Cancer Journal for Clinicians, 52, 23-47.

    Jenkins, C.N., McPhee, S.J., Bird, J.A., Pham, G.Q., Nguyen, B.H., Nguyen, T., et al. (1999). Effect of a media-led education campaign on breast and cervical cancer screening among Vietnamese-American women. Preventive Medicine, 28, 395-406.

    Kaneko, M., Eguchi, K., Ohmatsu, H., Kakinuma, R., Naruke, T., Suemasu, K., et al. (1996). Peripheral lung cancer: Screening and detection with low-dose spiral CT versus radiography. Radiology, 201, 798-802.

    Kantoff, P.W., Wishnow, K.I., & Loughlin, K.R. (1996). Prostate cancer: A multidisciplinary guide. Boston: Blackwell Science.

    Khullar, S.K., & DiSario, J.A. (1997). Colon cancer screening: Sigmoidoscopy or colonoscopy. Gastrointestinal Endoscopy Clinics of North America, 7, 365-386.

    Kronberg, O. (1991). Population screening for colorectal cancer, the goals and means. Annals of Medicine, 23, 373-379.

    Lieberman, D.A., & Weiss, D.G. (2001). One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. New England Journal of Medicine, 345, 555-560.

    Madigan, M.P., Ziegler, R.G., Benichou, J., Byrne, C., & Hoover, R.N. (1995). Proportion of breast cancer cases in the United States explained by well-established risk factors. Journal of the National Cancer Institute, 87, 1681-1685.

    Mandel, J.S., Band, J.H., Church, T.R., Snover, D.C., Bradley, G.M., Schuman, L.M., et al. (1993). Reducing mortality from colorectal cancer by screening for fecal blood. Minnesota Colon Cancer Control Study. New England Journal of Medicine, 328, 1365-1371.

    Marcus, A.C., & Crane, L.A. (1998). A review of cervical cancer screening intervention research: Implications for public health programs and future research. Preventive Medicine, 27, 13-31.

    Muller, A.D., & Sonnenberg, A. (1995). Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Annals of Internal Medicine, 123, 904-910.

    National Cancer Institute. (1999a). SEER incidence: Cervix uteri cancer. Retrieved May 1, 2002, from http://seer.cancer.gov/faststats/html/inc_cervix.html

    National Cancer Institute. (1999b). SEER mortality: Cervix uteri cancer. Retrieved May 1, 2002, from http://seer.cancer.gov/faststats/html/mor_cervix.html

    National Cancer Institute. (2001). Screening for ovarian cancer (PDQ). Retrieved July 27, 2001, from http://cancernet.nci.nih.gov

    Newcomb, P.A., Norfleet, R.G., Storer, B.E., Surawicz, T.S., & Marcus, P.M. (1992). Screening sigmoidoscopy and colorectal cancer mortality. Journal of the National Cancer Institute, 84, 1572-1575.

    Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., & Doll, R. (2000). Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. BMJ, 321, 323-329.

    Reich, J.M. (1995). More on lung cancer screening [Letter to the editor]. Chest, 108, 294-295.

    Reintgen, D.S., & Clark, R.A. (1996). Cancer screening. St. Louis, MO: Mosby.

    Ries, L.A., Wingo, P.A., Miller, D.S., Howe, H.L., Weir, H.K., Rosenberg, H.M., et al. (2000). The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer, 88, 2398-2424.

    Ries, L.A.G., Eisner, M.P., Kosary, C.L., Hankey, B.F., Miller, B.A., Clegg, L., et al. (2001). SEER cancer statistics review, 1973-1999. Bethesda, MD: National Cancer Institute.

    Rimer, B. (1994). Mammography use in the U.S.: Trends and the impact of interventions. Annals of Behavioral Medicine, 16, 317-326.

    Rimer, B., Conaway, M., Lyna, P., Glassman, B., Yarnall, K., Lipkus, I., et al. (1999). The impact of tailored interventions on a community health center population. Patient Education and Counseling, 37, 125-140.

    Saywell, R.M., Jr., Champion, V.L., Skinner, C.S., McQuillen, D., Martin, D., & Maraj, M. (1999). Cost-effectiveness comparison of five interventions to increase mammography screening. Preventive Medicine, 29, 374-382.

    Selby, J.V., Friedman, G.D., Quesenberry, C.P., Jr., & Weiss, N.S. (1992). A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. New England Journal of Medicine, 326, 653-657.

    Skinner, C.S., Strecher, V.J., & Hospers, H. (1994). Physicians' recommendations for mammography: Do tailored messages make a difference? American Journal of Public Health, 84, 43-49.

    Smith, R., Osuch, J.R., & Linver, M.N. (1995). A national breast cancer database. Radiologic Clinics of North America, 33, 1247-1257.

    Smith, R.A. (1997). Screening fundamentals. Journal of the National Cancer Institute Monographs, 22, 15-19.

    Steele, C.B., Miller, D.S., Maylahn, C., Uhler, R.J., & Baker, C.T. (2000). Knowledge, attitudes, and screening practices among older men regarding prostate cancer. American Journal of Public Health, 90, 1595-1600.

    Tarone, R.E., Chu, K.C., & Brawley, O.W. (2000). Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiology, 11, 167-170.

    Trends in screening for colorectal cancer-United States, 1997 and 1999. (2001). Morbidity and Mortality Weekly Report, 50, 162-166.

    U.S. Centers for Disease Control and Prevention. (2000a). CDC surveillance summaries. Morbidity and Mortality Weekly Report, 49(SS-46), 33-35.

    U.S. Centers for Disease Control and Prevention. (2000b). Data 2010. Retrieved May 15, 2001, from http://www.CDC.gov

    U.S. Preventive Services Task Force. (1996). Guide to clinical preventive services: Report of the U.S. Preventive Services Task Force (2nd ed.). Baltimore, MD: Williams and Wilkins.

    Wagner, R.F., Jr., Wagner, D., Tomich, J.M., Wagner, K.D., & Grande, D.J. (1985). Diagnoses of skin disease: Dermatologists versus nondermatologists. Journal of Dermatologic Surgery and Oncology, 11, 476-479.

    Winawer, S.J., Fletcher, R.H., Miller, L., Godlee, F., Stolar, M.H., Mulrow, C.D., et al. (1997). Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology, 112, 594-642.